![David B. Matias](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David B. Matias
Founder at Vodia Ventures LLC
Network origin in David B. Matias first degree
Entity | Entity type | Industry | |
---|---|---|---|
Vodia Ventures LLC
![]() Vodia Ventures LLC Investment ManagersFinance Vodia Ventures LLC (Vodia Ventures) is a venture capital subsidiary of Vodia Capital LLC founded in 2004 by David B. Matias and Julianne Zimmerman. The firm is headquartered in Lincoln, Massachusetts.
3
| Subsidiary | Investment Managers | 3 |
Vodia Capital LLC
![]() Vodia Capital LLC Investment ManagersFinance Part of Robertson Stephens Wealth Management LLC, Vodia Capital LLC provides investment advisory services. The company is based in Concord, MA. The company was founded by David B. Matias. David B. Matias has been the CEO since incorporation. Vodia Capital was acquired by Robertson Stephens Wealth Management LLC on December 13, 2022.
1
| Subsidiary | Investment Managers | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to David B. Matias via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Shire Pharmaceuticals, Inc.
![]() Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
GAIN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Boundless Impact Investing
![]() Boundless Impact Investing Miscellaneous Commercial ServicesCommercial Services Boundless Impact Investing operates as a research company. The private company is based in Greensboro, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
The Hebrew University of Jerusalem | College/University | Undergraduate Degree | |
LAVAN, Inc.
![]() LAVAN, Inc. Miscellaneous Commercial ServicesCommercial Services LAVAN, Inc. is a not-for-profit organization that advances the ecosystem of impact investing with Jewish values. LAVAN educates the next generation of Jewish leadership, builds local communities of impact investors, and facilitates meaningful dialogue at the nexus of financial decisions and Jewish values. The American company was founded by Avi Deutsch. | Miscellaneous Commercial Services | Founder | |
Candoo PBC
![]() Candoo PBC Miscellaneous Commercial ServicesCommercial Services Candoo PBC provides tech support and training specifically designed to help older adults use technology. It offers tech support and lessons for devices and software applications from phones, iPads and tablets, Alexa and computers to innovative home sensors and fall detection devices. The firm’s services include installation and setup, online only membership, tech support and lesson. The company was founded by Elizabeth Hamburg and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Reinventure Capital
![]() Reinventure Capital Investment ManagersFinance Reinventure Capital (Reinventure Capital) is a venture capital firm founded in 2014 by Edward Dugger III. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Payload Systems, Inc.
![]() Payload Systems, Inc. Engineering & ConstructionIndustrial Services Part of The Boeing Co., Payload Systems, Inc. provides science and engineering services for spaceflight and terrestrial applications. The company is based in Cambridge, MA. Payload Systems was acquired by Aurora Flight Sciences Corp., part of The Boeing Co. from November 08, 2017 on October 29, 2007. | Engineering & Construction | Corporate Officer/Principal | |
University of Maryland | College/University | Graduate Degree | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
PROTALIX BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
George Washington University | College/University | Undergraduate Degree | |
SOLENO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
AM-Pharma BV
![]() AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
Enterome SA
![]() Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
PHOTOCURE ASA | Medical Specialties | Director/Board Member | |
COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Naurex, Inc.
![]() Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Pharmaceuticals: Major | Director/Board Member | |
ArmaGen, Inc.
![]() ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Hospital/Nursing Management | Director/Board Member | |
DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
KAMADA LTD. | Biotechnology | Director/Board Member | |
Adolor Corp.
![]() Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Corporate Officer/Principal | |
TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
The Pennsylvania State University | College/University | Graduate Degree | |
Capella University LLC | College/University | Undergraduate Degree |
Statistics
International
United States | 25 |
Israel | 3 |
France | 3 |
Ireland | 2 |
Netherlands | 2 |
Sectoral
Health Technology | 16 |
Consumer Services | 7 |
Commercial Services | 4 |
Finance | 4 |
Producer Manufacturing | 3 |
Operational
Director/Board Member | 15 |
Corporate Officer/Principal | 12 |
Independent Dir/Board Member | 7 |
Undergraduate Degree | 4 |
Private Equity Investor | 3 |
Most connected contacts
Insiders | |
---|---|
Gwen Melincoff | 20 |
Julianne Zimmerman | 8 |
Avi Deutsch | 7 |
Brandon Frye | 2 |
- Stock Market
- Insiders
- David B. Matias
- Company connections